This vaccine is ineffective for half of Hungarians over the age of 80

New data suggests that the Chinese Sinopharm vaccine does not cause a rise of antibodies for a significant number of the elderly.

The Sinopharm vaccine is probably the most divisive one used in the fight against Covid. Many studies have surfaced during the past months on the effectiveness or rather on the ineffectiveness of the jab. Daily News Hungary already reported the findings of a Hungarian research investigating the immune reaction of those over 60. 

Biochemist Balázs Sarkadi and Tamás Ferenci, who works in biostatistics, conducted a research with the participation of 450 people. The subjects were examined at least two weeks after receiving the second dose of the vaccine. They published their results on Monday, which suggest the following:

• 90% of the subjects under the age of 50 produced antibodies after having received the Chinese jab
• Over the age of 60, the probability of not producing any antibodies is 25%
• When it comes to the elderly over 80, this probability increases to 50%
  
• For those around the age of 60, the likelihood of producing only a small number of antibodies is between 60-75%
• In the case of older people, this probability is even higher

According to the research, the level of antibodies depends neither on the sex of the patient nor on the time that passed after the second dose. The examinations were concluded with the same type of test that was used to monitor the functioning of the mRNA vaccines during the first and the second phase of the clinical research.